—
C+
C+ The full Closelook — membership. Open the C+ overview

BB Biotech AG (BION.SW) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — BB Biotech AG

BION.SW in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
BB Biotech AG is a closed-end investment company that holds a global portfolio of biotechnology equities, chosen through fundamental research rather than an index. It is managed by Bellevue Asset Management and is domiciled in Switzerland, giving investors exposure to the sector rather than to any single drug or therapy.
Where it sits in the stack
BB Biotech carries no seat in our index and does not sit inside the AI build-out layers; it belongs to the Biotechnology sleeve of our wider universe, where it acts as a buyer of listed biotech shares rather than a supplier within any technology stack.
Who it is priced against
Closelook's peer group is not defined for this name; the comparison the market draws is with other listed biotechnology investment trusts, such as Worldwide Healthcare Trust.
Why Closelook tracks it
It holds no Closelook index seat and carries no score yet; the diary has not quoted it in the Morning 10 or in any edition so far.
What the diary watches
Whether the recent run of down sessions and the gap to the 200-day average mark a shift in sentiment toward listed biotech portfolios generally.

BB Biotech AG (BION.SW) trades on the SW exchange in Switzerland, classified under Healthcare.

The Closelook company score reads 74/100 composite (momentum 73, quality 95, valuation 81) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for BION.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Healthcare · Switzerland · 5 names with week and year-to-date

Peer group

Healthcare · Switzerland

Scored names in the same sector and country from the Closelook universe.

Compared against BION.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in Europe: +1.1% week · −3.6% month · +0.3% quarter · −6.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is BB Biotech AG (BION.SW)?

BB Biotech AG trades as BION.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is BION.SW in a Closelook index?

Not currently — BB Biotech AG is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

What is BB Biotech AG's Closelook composite score?

74 out of 100, with momentum 73, quality 95 and valuation 81 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does BION.SW trade against its moving averages?

Pullback inside an uptrend stack: Trades -1.3% vs the 50-day and +12% vs the 200-day average, 8.4% below the 52-week high and +58.5% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does BB Biotech AG do?

BB Biotech AG is a closed-end investment company that holds a global portfolio of biotechnology equities, chosen through fundamental research rather than an index. It is managed by Bellevue Asset Management and is domiciled in Switzerland, giving investors exposure to the sector rather than to any single drug or therapy. Closelook's peer group is not defined for this name; the comparison the market draws is with other listed biotechnology investment trusts, such as Worldwide Healthcare Trust.

Where does BB Biotech AG sit in the AI build-out?

BB Biotech carries no seat in our index and does not sit inside the AI build-out layers; it belongs to the Biotechnology sleeve of our wider universe, where it acts as a buyer of listed biotech shares rather than a supplier within any technology stack. It holds no Closelook index seat and carries no score yet; the diary has not quoted it in the Morning 10 or in any edition so far.

What does this page show?

A live price chart with SMA overlays and drawing tools for BION.SW, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe